MOESM1 of Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trial

Additional file 1.  Summary of SABR-related mortality and ILD-specific toxicity. Reproduced from Chen et al [10].